Tonix Pharmaceuticals Holding Corp. receives FDA nod for Tonmya, a breakthrough fibromyalgia treatment. Click here to find ...
Tonix plans to initiate potential pivotal Phase 2 HORIZON study of TNX-102 SL in adults with major depressive disorder in mid-2026More than 21 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback